Clinical Trials
4 trialsNCT00082719 2015-05-14
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01094964 2013-08-12
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00004122 2013-02-01
BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT00330707 2011-03-04
Combined Use of BCG and Interferon Alpha in Bladder Cancer
National University Hospital, Singapore
Phase 2/3 Completed